CDR2 Antibodies

AND CDR2 ELISA kits, CDR2 Proteins

Many biological assays use antibodies to detect CDR2, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with CDR2 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop CDR2 antibodies...

We validate the specificity of these antibodies to CDR2 by testing them on tissues known to express CDR2 positively and negatively. Browse below to find the CDR2 antibody that suites your experiment. We have 3 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: CDH12 Next: CD52

CDR2 Infographic by Boster Bio

All CDR2 Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

Anti-CDR2 Antibody Picoband®

7 Q&As

Human, Mouse

$370
Cat # A02973-1
100 μg/vial

Anti-CDR2 Antibody Picoband®

Human

ELISA, Flow Cytometry, IHC, WB

$370
Cat # A02973-2
100 μg/vial

CDR2 (NM_001802) Human Over-expression Lysate

Human

$628
Cat # LS001039
100 µg

CDR2 Overview

Facts about Cerebellar degeneration-related protein 2.

CDR2 3D structure. Source: alphafold

Cerebellar degeneration-related protein 2 (CDR2)

Gene Information

Human
Gene Name:	CDR2
Uniprot:	Q01850
Entrez:	1039

Family

Belongs to:

CDR2 family

Alternative Names

CDR62; cerebellar degeneration-related protein (62kD); cerebellar degeneration-related protein 2; cerebellar degeneration-related protein 2, 62kDa; Major Yo paraneoplastic antigen; Paraneoplastic cerebellar degeneration-associated antigen; PCD17; Yo paraneoplastic antigen; Yo

Molecular Weight

Mass (kDA):
51.855 kDA

Genomic Context


Human

Location:	16p12.2
Sequence:	16; NC_000016.10 (22345936..22374619, complement)

Diseases

Paraneoplastic Cerebellar Degeneration
Malignant Neoplasms
Neoplasms
Autoimmune Reaction
Paraneoplastic Syndromes
Candidiasis
Cerebellar Diseases
Autoimmune Diseases
Ovarian Neoplasm
Carcinoma
Hiv Infections
Adenocarcinoma

Lupus Erythematosus, Systemic
Lymphoma
Infective Disorder
Nervousness
Paraneoplastic Syndromes, Nervous System
Mammary Neoplasms

Interacting Proteins

ANKRD36BP1
C1orf216
C2CD6
C4orf46
CCDC153

CDR2L
CHIC2
COX5B
EIF4E2
ENKD1

FAM110A
FAM161A
HAUS1
HDAC4
HGS

KANSL1
KIFC3
LENG1
LIN37
MORF4L2

MRPL28
PKN1
RCOR3
RSPH14
SCNM1

SH2D4A
SMARCE1
TBC1D22B
TCHP
TRIM23

TTR
TXLNA
WDYHV1

Pathways

Drug Resistance
Immune Response
Pathogenesis
Gene Conversion
Transport
Cell Cycle
Mitosis
Glycosylation
Localization
Cell Adhesion
Cell Activation
Cytokinesis
Cell Division

Secretion
Cell Recognition
Cell Death
T Cell Activation
Reverse Transcription
Interphase
Hypersensitivity

PTMs

Glycosylation
Phosphorylation
Cleavage
Biotinylation

Deamidation
Hydroxylation
Dephosphorylation
Ubiquitination

Research Areas

Cancer
Immune System Diseases
Immunology
Neuroscience

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/CDR2

References

PMID: 2014264 by Fathallah-Shaykh H., et al. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration.

PMID: 2260856 by Sakai K., et al. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration.